ISLAMABAD, Nov 11 (DNA):The Drug Regulatory Authority of Pakistan (DRAP) and the Government of Punjab have signed a Memorandum of Understanding (MoU) to strengthen regulatory coordination, harmonize practices and ensure consistent implementation of therapeutic goods regulations across the country.
The agreement aims to promote a unified, standardized and coordinated National Regulatory System (NRS) in line with the World Health Organization’s Global Benchmarking Tool (WHO GBT) framework.
With Punjab joining other provinces that have already signed similar agreements, the initiative is expected to further strengthen inter-provincial coordination, harmonize regulatory practices and improve surveillance of therapeutic goods nationwide.
The collaboration reflects a shared commitment to strengthening Pakistan’s regulatory framework, advancing WHO Global Benchmarking objectives and ensuring the quality, safety and efficacy of therapeutic goods across the country.
